• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
DING Dong,LI Jiani,QI Ran,LU Yuan,YANG Yong.Research advances of the ulcerative colitis[J].Journal Of Pharmaceutical Research,2017,36(7):404-408[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 4159times   Download 3390次 QR Code for this article
Scan with your phone!
溃疡性结肠炎的研究进展
丁栋,李佳妮,齐冉,陆源,杨勇
Font:Larger+|Default|Smaller-
(中国药科大学药物科学研究院,江苏 南京 211198)
摘要:
溃疡性结肠炎是一种由免疫反应介导的慢性易复发的炎症肠病。最新研究表明多种基因异常导致T细胞对一系列肠道共生菌产生异常免疫反应,进而损伤肠黏膜是其主要病因。多种环境因素能瞬时破坏黏膜屏障,与基因异常共同作用,扰乱免疫反应或者肠道菌群,导致了溃疡性结肠炎的异质性。溃疡性结肠炎的异质性决定了其诊断的复杂性,目前的诊断主要依赖临床评估,内窥镜检测,组织学和生物学相结合的方法。治疗药物主要包括氨基水杨酸盐,免疫抑制剂和生物学抗体等。本文总结了溃疡性结肠炎的研究现状及进展,为结肠炎预防、诊断、治疗以及新药研发提供了新的策略。
关键词:  溃疡性结肠炎  分类  发病机制  诊断
DOI:10.13506/j.cnki.jpr.2017.07.010
基金项目:国家自然科学基金重大研究计划(No.91529304)
Publication Date:July 25, 2017
Research advances of the ulcerative colitis
DING Dong,LI Jiani,QI Ran,LU Yuan,YANG Yong
(Drug Research Institute,China Pharmaceutical University, Nanjing 211198,China)
Abstract:
Ulcerative colitis is a chronic and relapsing inflammatory bowel disease that is immunologically mediated.New studies indicate that various genetic abnormalities lead to overly aggressive T-cell responses to a subset of commensal enteric bacteria and in turn,injure the intestinal mucosa as the main pathogenesises.The instantaneous impact of environmental factors on mucous membrane barrier,disrupting the immune response or intestinal flora with genetic abnormalities,results in the heterogeneity of ulcerative colitis.The heterogeneity determines the diversity of its diagnosis which includes clinical assessment,endoscopic detection,histology and biology.The maintherapeutic of ulcerative colitis are aminosalicylates,immunomodulators and biologics.This paper summarized the research status of ulcerative colitis and in order to provide a new strategy for prevention,diagnosis,treatment and drug research of ulcerative colitis.
Key words:  Ulcerative colitis  Classification  Pathogenesis  Diagnosis
Today's Visits:511    Total Visits:2383242
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.